Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

INmune Bio, Inc. (INMB) vs LeonaBio, Inc. (LONA)

INmune Bio, Inc. and LeonaBio, Inc. are both Biotechnology companies. INmune Bio, Inc. and LeonaBio, Inc. are of similar size ($55.5M and $54.3M). Across the 10 metrics below, INmune Bio, Inc. leads on 7 and LeonaBio, Inc. on 3.

Valuation

Metric INMB LONA Biotechnology median
P/E n/m n/m 7.88
P/S 401.77 n/m 11.47
P/B 2.66 2.30 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 301.47 n/m 10.73
Earnings yield (33.00%) (708.88%) (28.84%)
Free cash flow yield (30.30%) (80.10%) (23.03%)

Profitability

Metric INMB LONA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (74.82%) (431.39%) (57.72%)
Return on assets (57.08%) (306.05%) (49.22%)
Return on invested capital (646.94%) 0.00% 0.00%

Growth

Metric INMB LONA Biotechnology median
Revenue growth (TTM) (51.61%) — 5.64%
EPS growth (last fiscal year) 11.85% 1.98% —
Revenue growth, 5-year CAGR 35.37% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INMB LONA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.04 7.01 4.73
Net debt to EBITDA 0.52 0.87 0.96

Dividend

Metric INMB LONA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric INMB LONA Biotechnology median
Market cap 55.51m 54.26m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack